Effects of ulinastatin administered at different time points on the pathological morphologies of the lung tissues of rats with hyperthermia

Experimental and Therapeutic Medicine

Volumn 7, Issue 6, 2014, Pages 1625-1630

  Qin, Zai Sheng ^a   Tian, Pei ^a   Wu, Xia ^a   Yu, Hong Mei ^a   Guo, Na ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Pulmonary histopathology; Systemic hyperthermia; Ulinastatin

Indexed keywords

SODIUM CHLORIDE; ULINASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; BRONCHUS; CELL STRUCTURE; CELL SWELLING; CONTROLLED STUDY; DRY WEIGHT; EDEMA; EMPHYSEMA; HEATING; HISTOPATHOLOGY; HYPEREMIA; HYPERTHERMIA; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS WALL; LUNG PARENCHYMA; MALE; MICROSCOPY; MICROVILLUS; MITOCHONDRION; NEUTROPHIL; NONHUMAN; PATHOLOGY; RAT; RECTUM TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84898476468     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1656     Document Type: Article

References (26)

1. Szasz A, Szasz N and Szasz O (eds): Hyperthermia results and challenges. In: Oncothermia: Principles and Practices. Springer, Netherlands, pp17-18, 2011.
2. Takagi M, Sakata K, Someya M, et al: The combination of hyperthermia or chemotherapy with gimeracil for effective radiosensitization. Strahlenther Onkol 188: 255-261, 2012.
3. Varghese GM, John G, Thomas K, Abraham OC and Mathai D: Predictors of multi-organ dysfunction in heatstroke. Emerg Med J 22: 185-187, 2005.
4. Leon LR, Blaha MD and DuBose DA: Time course of cytokine, corticosterone, and tissue injury responses in mice during heat strain recovery. J Appl Physiol (1985) 100: 1400-1409, 2006.
5. Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T and Yoshioka H: Association between heat stress protein 70 induction and decreased pulmonary fibrosis in an animal model of acute lung injury. Lung 185: 287-293, 2007.
6. Noguchi I, Ohno H, Takano K, Shimada R, Sasao M and Shimonaka H: Fatal hyperthermia due to dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101: e61-e64, 2006.
7. Hernandez JF, Secrest JA, Hill L and McClarty SJ: Scientific advance in the genetic understanding and diagnosis of malignant hyperthermia. J Perianesth Nurs 24: 19-34, 2009.
8. Firstenberg M, Abel E, Blais D and Andritsos M: Delayed malignant hyperthermian after routine cononary artery bypass. Ann Thorac Surg 89: 947-948, 2010.
9. Pişkin B, Atac MS, Konca E, Yildirim M, Avsever H and Sevketbeyoǧlu H: A Suspected case of malignant hyperthermia after tooth extraction: case report. J Oral Maxillofac Surg 69: 1331-1334, 2011.
10. Ouyang MW, Qin ZS, Chen ZQ, Xiao JF, Liu XJ and Gu MN: A report of fulminant malignant hyperthermia in a patient during operation. J South Med Univ 30: 2611-2612, 2010 (In Chinese).
11. Okuhama Y, Shiraishi M, Higa T, et al: Protective effects of ulinastatin against ischemia-reperfusion injury. J Surg Res 82: 34-42, 1999.
12. Inoue K, Takano H, Sato H, Yanagisawa R and Yoshikawa T: Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice. Immunopharmacol Immunotoxicol 31: 446-450, 2009.
13. Wang W, Huang W, Chen S, Li Z, Wang W and Wang M: Changes of tumor necrosis factor-alpha and the effects of ulinastatin injection during cardiopulmonary cerebral resuscitation. J Huazhong Univ Sci Technology Med Sci 24: 269-271, 2004.
14. Inoue K, Takano H, Yanagisawa R, et al: Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med (Maywood) 230: 281-287, 2005.
15. Bae HB, Jeong CW, Li M, Kim HS and Kwak SH: Effects of urinary trypsin inhibitor on lipopolysaccharide-induced acute lung injury in rabbits. Inflammation 35: 176-182, 2012.
16. Zhang X, Liu F, Liu H, et al: Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase. Inflamm Res 60: 569-575, 2011.
17. Bouchama A, Roberts G, Al Mohanna F, et al: Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke. J Appl Physiol (1985) 98: 697-705, 2005.
18. Wang HM, Bodenstein M and Markstaller K: Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res 40: 305-316, 2008.
19. Li JH, Zhu GB, Chen L, Wang TR and Li SH: The experimental study of the heat stress on the functional injury and persisting injury. Sichuan Medical Journal 31: 1747-1750, 2010 (In Chinese).
20. Marino A, Pellegrini F, Lucchesi AM, Roncucci P, Cosimi A and Logi G: Multiorgan damage in exertion heatstroke. Minerva Anestesiol 58: 393-395, 1992 (In Italian).
21. Qian LJ, Gong JB and Cheng SQ: Mitochondrial mechanism of heat stress-induced injury in rat cardiomyocyte. Zhongguo Ying Yong Sheng Li Xue Za Zhi 16: 133-136, 2000 (In Chinese).
22. Zheng CY, Zhang W and Liang YG: Inflammatory factor level and ulinastatin intervention in the early stage of heat stress in rats. Journal of Medical Postgraduates 24: 25-28, 2011 (In Chinese).
23. Naučiene Z, Zukiene R, Degutyte-Fomins L and Mildažiene V: Mitochondrial membrane barrier function as a target of hyperthermia. Medicina (Kaunas) 48: 249-255, 2012.
24. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C and Matsumoto A: Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 15: 101-105, 2001.
25. Anetseder M, Hager M, Müller CR and Roewer N: Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test. Lancet 359: 1579-1580, 2002.
26. Nishio H, Sato T, Fukunishi S, et al: Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature. Leg Med (Tokyo) 11: 142-143, 2009.